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The typing of non-tuberculous mycobacteria (NTM) is important from a clinical
and epidemiological perspective. The polymerase chain reaction-restriction enzyme
analysis (PRA) method and DNA sequence analysis method were utilized to target a
gene region that codes the 65-kDa heat-shock protein for typing 150 suspected NTM
samples isolated from the respiratory tract.Mycobacterium abscessus, Mycobacterium
xenopi, Mycobacterium fortuitum, and Mycobacterium peregrinum were most fre-
quently found by both methods. Six isolates that could not be deﬁned by the PRA
method were deﬁned as Nocardia cyriacigeorgica, Nocardia abscessus, and Myco-
bacterium intracellulare by DNA sequence analysis. Discordance between the results
of the two methods was observed for only one isolate. The isolate that was deﬁned as
Mycobacterium gordonae type 6 by the PRA method was deﬁned as Mycobacterium
senegalense by sequence analysis. The PRA method is simple and gives rapid results.
Compared with DNA sequence analysis, it gives consistent and reliable results up to a
ratio of 90%. DNA sequence analysis is the gold standard method in which all strains
can be deﬁned. However, given our laboratory conditions, its disadvantage is that it
takes longer to reach a diagnosis than through the PRA method.
Keywords: non-tuberculous mycobacteria, DNA sequence analysis, restriction
enzyme analysis, heat-shock protein
Introduction
Non-tuberculous mycobacteria (NTM) represents a large number of non-
pathogenic mycobacterial species other than the Mycobacterium tuberculosis
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complex (MTC) (Mycobacterium bovis, M. bovis Bacille Calmette–Guérin,
Mycobacterium africanum, Mycobacterium canetti, Mycobacterium microti,
Mycobacterium pinnipedii, and Mycobacterium caprae) and Mycobacterium
leprae [1].
Today, more than 170 types of NTM are found intensely in nature,
especially in soil and water sources, including drinking water systems (http://
www.bacterio.net/mycobacterium.html). These may lead to diseases especially in
people who undergo immune-suppressive treatment or who suffer from immune
deﬁciency, but NTM infections can also be observed in people with normal
immune systems. The NTM can infect many systems, primarily respiratory, and
can lead to various clinical pictures [2]. The prevalence of pulmonary NTMs
varies among countries, but it is increasing worldwide and becoming an important
public health problem, especially for elderly people. Although the exact reason for
this increase is not known, it can be explained by the increase in the patient
population sensitive to NTM, the use of advanced molecular-based tests, the rise in
environmental mycobacterial infection sources, and more awareness among
clinicians against NTMs. Because NTMs can be found everywhere as saprophytes,
their isolation from the respiratory tract does not show that they are always
causative agents. Therefore, the diagnosis should be veriﬁed clinically, microbi-
ologically, and radiologically [3–5].
NTMs should be deﬁned at a species level, because they are resistant to
classic antituberculosis drugs and the different types have different susceptibilities
to antibiotics. Additionally, the deﬁnition is necessary to enable the collection of
epidemiological data. In this study, the polymerase chain reaction (PCR)-restriction
enzyme analysis (PRA) method and DNA sequence analysis method were used to
deﬁne samples isolated from the respiratory tract that were not MTC and were
suspected of being NTM. The objective was to compare the results of the two




We studied 185 NTM suspect samples that were detected not to be MTC
from respiratory tract samples, between 2004 and 2010, at the Dokuz Eylul
University Hospital’s Mycobacteriology Laboratory. The study was funded by the
university and conﬁrmed by its ethics committee. Isolates from 150 patients were
included in the study, after excluding the isolates of repeated samples and those
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that were not reproduced after passage. The following were used as quality control
strains: Mycobacterium intracellulare type 1 (ATCC 13950), Mycobacterium
abscessus tip 1 (ATCC 19977), Mycobacterium fortuitum type 1 (ATCC 6841),
Mycobacterium gordonae type 1 (ATCC 14470), Mycobacterium scrofulaceum
type 1 (ATCC 19981), Mycobacterium szulgai (ATCC 35799), Mycobacterium
kansasii type 1 (ATCC 12478), and M. tuberculosis H37Rv.
Identiﬁcation of NTM
The MTC and NTM distinction was made by p-nitro-α-acetylamino-β-
hydroxypropiophenone (NAP) and p-nitro benzoic acid. Phenotypic and conven-
tional methods were used for those that could not be differentiated. An amount of
0.5 ml was taken from BACTEC 12B and MGIT 960 bottles that belonged to
NTM-suspected samples, their fresh passage was made to the Löwenstein–Jensen
(LJ) medium and their growth feature was controlled.
DNA extraction
Colonies from the LJ mediums, where the growth was detected, were added
to a 1-ml physiological saline solution and centrifuged at 11,000× g for 1 min.
A 250-μl 1× TE tampon (10 mM Tris, 1 mM EDTA, pH 8.0) was added to the
precipitate and mixed using vortex agitation. Then, it was again centrifuged at
11,000× g for 1 min and a 250-μl 1× TE tampon was added to the precipitate and
incubated at 95 °C for 10 min. The centrifuge processing was repeated and the
supernatant portion was maintained at −20 °C as a DNA extract until inclusion in
the study.
Polymerase chain reaction (PCR)
The heat-shock protein 65 (hsp65) gene region of NTM was reproduced by
the PCR reaction. The mixture, whose total volume was 50 μl, included the isolated
DNA sample, dH2O, MgCl2 (25 mM), dNTP (10 mM), 10× Buffer, Primer 1 (Tb11;
5′-ACCAACGATGGTGTGTCCAT-3′), Primer 2 (Tb12; 5′–CTTGTCGAACCG-
CATACCCT-3′), and hot start taq DNA polymerase. This mixture was placed in
a “thermal cycler” device (Techne TC-412, Bioblock, Illkirch, France) and subjected
to initial denaturation at 95 °C for 5 min. Then, 40 cycles were applied: 94 °C for
1 min, 60 °C for 1 min, 72 °C for 1 min, and again for 10 min. The reaction was
stopped at 4 °C and the ampliﬁcation products were shown at gel electrophoresis [6].
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A 50-base pair (bp) DNA reagent was loaded on the ﬁrst and the last wells as an
indicator of molecular magnitude and PCR was loaded on the other wells. After
applying electrophoresis at 130 V for 45 min, the gel was viewed on a UV
transilluminator.
Restriction enzyme analysis
For both enzymes (BstE II and Hae III), a 10-μl PCR product was added to
the mixtures that contained 12.0 μl dH2O, 2.5 μl 5× buffer, and 0.5 μl enzyme. The
mixture that contained BstE II was maintained at 60 °C for 1 h and the mixture that
contained Hae III was maintained at 37 °C for 1 h. After the cutoff period, the
patterns were viewed at 4% metaphor gel. The results are available in http://app.
chuv.ch/prasite/index.html.
DNA sequence analysis
A 40-μl portion of the PCR products equaling 441 bp in length at agarose
gel electrophoresis, at a suitable clearness and viewed as pure band, were saved
at 2–8 °C and sent to Korea for puriﬁcation and double-sided sequencing
(Macrogen Inc., Korea). The Tb11 and Tb12 primers used at PCR reaction
were used for the sequencing process. The results were e-mailed to us as
chromotogram ﬁles in ab1 ﬁle format and converted to fasta format by the
BioEdit (Biological sequence alignment editor; Ibis Biosciences, Inc., Canada)
program and recorded. These sequences were compared with the reference
mycobacteria hsp65 gene region downloaded from Genbank (National Center
for Biotechnology Information, National Library of Medicine, USA) and were
aligned using the BioEdit program. The DNA sequences in aligned fasta format
were analyzed using the Basic Local Alignment Search Tool (National Library
of Medicine, USA) program, and 150 isolates were deﬁned at the species level.
Results
Table I shows a distribution by years of 150 patients’ samples, which were
not MTC, but were detected to have NTM growth. About 42.7% (64 out of 150) of
the isolates belonged to female patients. The sampling distribution was 64 (42.7%)
sputum, 73 (48.6%) bronchial lavage, 11 (7.3%) bronchoalveolar lavage, and 2
(1.3%) tracheal secret.
When the sequences obtained by the DNA sequence analysis were com-
pared with the standard sequences at the GenBank, 51 of the isolates showed
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100% compatibility, 94 showed 99%, 1 showed 98%, 3 showed 97%, and 1
showed 95%. Out of 14 different microorganisms that were detected,we had 12
different NTM types and 2 different Nocardia types. The most isolated NTM type
was M. abscessus with 69 (46%), whereas the least-deﬁned NTM types were
Mycobacterium porcinum, Mycobacterium avium, and Mycobacterium senega-
lense with one isolate each (0.7%).
The PRA method could not deﬁne 6 of the 150 isolates.M. abscessus type 1
was the most isolated NTM with 69 isolates (46%) (Figures 1 and 2). The six
isolates that could not be deﬁned by PRA were deﬁned by the DNA sequence
analysis as Nocardia cyriacigeorgica (3/6), Nocardia abscessus (2/6), and
M. intracellulare (1/6). The isolate deﬁned as M. gordonae type 6 by PRA was
deﬁned as M. senegalense by sequence analysis (Table II). The distribution by
years of the deﬁned isolates can be seen in Table III.







included in the study
Number of samples
arriving at laboratory
2004 46 31 20 1,789
2005 80 10 4 2,239
2006 94 15 13 2,230
2007 99 38 35 2,630
2008 55 50 46 2,514
2009 83 15 12 2,750
2010 64 26 20 2,648
Total 521 185 150 16,800
Note: MTC: Mycobacterium tuberculosis complex; NTM: non-tuberculous mycobacteria.
Figure 1. PCR bands views obtained from NTMs. M: marker (50 bp), 1-12 wells; study samples
(expected band size: 441 bp)
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Figure 2. PCR-restriction enzyme analysis cutting patterns. M: marker (50 bp); B: band patterns of
BstE II enzyme cutting products; H: band patterns of Hae III enzyme cutting products; BI and H1:
KK2 [Mycobacterium abscessus type 1(ATCC 19977)] cutting patterns, for BstE II enzyme 235-201
bp, forHae III enzyme 145-70-60 bp. Other wells; study samples






M. abscessus type 1 M. abscessus 69 (46%)
M. xenopi type 1 M. xenopi 26 (17.3%)
M. fortuitum type 1, M. fortuitum
s. acetamidolyticum type 1
M. fortuitum 13 (8.7%)
M. porcinum type 1, M. septicum type 1,
M. peregrinum tip 2
M. peregrinum 13 (8.7%)
M. porcinum type 1, M. septicum type 1,
M. peregrinum type 2
M. porcinum 1 (0.7%)
M. intracellulare type 1, M. chimaera type 1 M. intracellulare 5 (3.3%)
M. simiae type 5, M. lentiﬂavum type 1,
M. ﬂorentinum type 1
M. lentiﬂavum 5 (3.3%)
M. genavense type 2, M. simiae type 1 M. simiae 4 (2.7%)
M. colombiense type 1, M. avium s. avium
type 2
M. avium 1 (0.7%)
M. avium s. avium type 1 M. avium izolat 2 (1.3%)
M. avium s. Paratuberculosis type 1
M. avium s. Silvaticum type 1
M. massiliense type 1, M. bolletii type 1,
M. abscessus type 2
M. bolletii 2 (1.3%)
M. chelonae type 1 M. chelonae type 2 (1.3%)
Unidentiﬁed 2 isolate Nocardia abscessus 2 (1.3%)
Unidentiﬁed 3 isolate Nocardia cyriacigeorgica 3 (2%)
Unidentiﬁed 1 isolate M. intracellulare 1 (0.7%)
M. gordonae type 6 M. senegalense 1 (0.7%)
Total 150 (100%)
Note: PRA: PCR-restriction enzyme analysis.
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Discussion
The biochemical tests are not suitable for routine usage in the deﬁnition of
NTM because they are not practical, require a long time, can only distinguish
certain types from each other, and are inadequate in a deﬁnition of new
mycobacteria types. Nowadays, in-house or commercial molecular-based tests
are frequently used in deﬁning types of mycobacteria. The cutting patterns
obtained by the BstE II and Hae III enzymes are type speciﬁc and allow for the
deﬁnition of many mycobacteria that are clinically important. The PRA method is
used by many laboratories for being easy, fast, and repeatable [6, 7]. Some
commercial systems that use DNA probe technology, such as the AccuProbe
system (Hologic GenProbe, San Diego, CA), the INNO-LiPA Mycobacteria
system (Fujirebio Europe, Ghent, Belgium), and the GenoType Mycobacterium
system (Hain Lifescience, Nehren, Germany), are used in the deﬁnition of NTMs.
However, some probes used in the commercial systems are not 100% speciﬁc and
in addition to what is declared by producers, some cross-reactions can be observed
[8, 9]. Sequence analysis is the reference method in the deﬁnition of mycobacteria
and, for this purpose, the 16S rRNA, hsp65, ITS, gyrB, recA, and rpoB gene
regions are targeted. Common properties of these gene regions are that they exist
in all mycobacteria and include sequences that are well protected from mutation
and are variable speciﬁc to each type. 16S rRNA and hsp65 are the most important
and most frequently used gene regions [10, 11]. In this study, we compared the
Table III. Distribution by years of the deﬁned isolates
Identiﬁed isolates 2004 2005 2006 2007 2008 2009 2010 Total
M. abscessus 6 3 12 16 26 5 1 69
M. xenopi 1 – – 8 10 5 2 26
M. peregrinum – – – – 2 1 10 13
M. fortuitum 6 1 – 3 3 – – 13
M. intracellulare 1 – – 5 – – – 6
M. simiae – – – 1 2 – 1 4
M. lentiﬂavum 2 – – – 2 – 1 5
M. avium 1 – – – – 1 1 3
N. cyriacigeorgica 3 – – – – – – 3
N. abscessus – – – 2 – – – 2
M. chelonae – – – – – – 2 2
M. bolletii – – – – – – 2 2
M. senegalense – – – – 1 – – 1
M. porcinum – – 1 – – – – 1
Total 20 4 13 35 46 12 20 150
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results obtained by the hsp65 PRA method with the results of the reference
method, DNA sequence analysis.
Our DNA sequence analysis results with the PRA method were compati-
ble with 95.3% (143/150) and incompatible with 0.6% (1/150). The study by
Chimara et al. [12] indicated 90.3% compatibility between the two methods, and
the PRA method deﬁned only 1.2% of the samples incorrectly. Sajduda et al.
evaluated 38 reference strains by the PRA method and observed that the
dimensions of the cutting patterns were 7 bp smaller than the sequence analysis.
However, they observed that the repeatability of PRA patterns and the accuracy
level of the results were high. In the same study, they blindly applied the 64
strains to the traditional biochemical tests, the commercial INNO-LiPA method,
and DNA sequence analysis. In the biochemical tests, they found that 14 of the
64 isolates were deﬁned incorrectly, but that correct results were yielded with
78%. Despite that, they observed that the results obtained by the PRA method
were compatible with INNO-LiPA by 89% and by DNA sequence analysis by
93.3% [13]. Gürtler et al. [14] identiﬁed mycobacteria species with 16S-23S
rDNA (ISR)-restriction fragment site polymorphisms rapidly between 2 days
and 4 weeks and all identiﬁcations were found to be compatible with DNA
sequencing. Important advantages of the PRA method are that it can be applied
easily, gives results quickly, and obtains over 90% conformity in the results.
However, a big disadvantage of the PRA method is that the band length is
evaluated visually, which makes standardization and evaluation of small band
patterns (especially cut by Hae III) difﬁcult. Furthermore, a single base change
can lead to the appearance or disappearance of a new cutting area [15]. For
instance, a point mutation in one of the cutting pattern regions can shift the
typical PRA model ofM. malmoense to aM. marinum-speciﬁc PRA model [16].
The parasite website used for interpreting the PRA cutting patterns is helpful.
However, it does not use the real dimension of manual cutting patterns, but
instead uses the patterns reported by publications, which may lead to problems in
evaluation. Although the PRA method is useful for many types, it cannot be used
for the taxonomy of new types [17]. The restriction enzymes used in this study
caused the production of identical cutting patterns for different mycobacteria
types (for instance, M. porcinum type 1, M. septicum type 1, M. peregrinum
type 2, BstE II 235–210 bp, and Hae III 140–125–100 bp). Therefore, changing
these restriction enzymes with more distinctive enzymes seems necessary for a
deﬁnite distinction.
Özçolpan et al. [18] deﬁned ten different types in their sequence analysis
study that targeted hsp65 and 16S rRNA in the deﬁnition of 101 NTM isolates.
M. porcinum (39.60%), Mycobacterium lentiﬂavum (35.65%), and M. abscessus
(5.64%) were the most isolated types. A sequence analysis carried out in four
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centers in Turkey deﬁned 17 different types in 90 NTM isolates; M. gordonae
(23%), M. abscessus (14%), and M. lentiﬂavum (10%) were determined to be the
most frequently isolated types [19]. Babalık et al. [20] examined 75 NTM cases,
43% of which were deﬁned by the hsp65 PRA method, and M. abscessus (28%),
M. avium complex (25%), and M. kansasii (16%) were the most frequently seen
NTMs. Velayeti et al. analyzed 96 articles that mentioned 1,751 NTM isolates in
the Middle Eastern countries and found that M. fortuitum was among the slow-
growing NTMs and M. avium complex was among the fast-growing NTMs. In the
same study, they analyzed 21 articles published in Turkey between 1993 and 2013
and the frequency order of 280 NTM isolates were deﬁned as follows: M. avium
complex (54/280),M. gordonae (53/280),M. fortuitum (48/280), andM. abscessus
(45/280) [21]. The NTMs predominantly exist in soil and water, environments that
are basic sources of infection. Therefore, the reason for the differences of dominant
types between laboratories is considered to be a result of different environmental
conditions [22].
In this study, six isolates considered to be NTM could not be deﬁned by the
PRA method. These samples for during the period 2004–2007 were routinely
processed by the LJ and BACTEC 460 TB systems, and the NAP test was used to
make the MTC and NTM distinction. Five isolates suspected of being NTM, which
were proved not to be MTC by the NAP test, did not present any band pattern with
the BstE II (440-0-0) and Hae III (0-0-0-0) enzymes used in the PRA. The
bacteriological and clinical properties of Nocardias are similar to those of myco-
bacteria and should additionally be considered for a differential diagnosis. The
mycobacteria can be distinguished from each other easily and quickly by BstE II
cutting patterns with the PRA, but some publications indicate that other actino-
mycetes that also contain Nocardias do not have BstE II cutting patterns. It has been
reported that this property can be used to deﬁne nocardias. However, Brunello et al.
[23] have shown that the BstE II (440-0-0) cutting patterns of some mycobacteria
(Mycobacterium conﬂuentis, Mycobacterium gilvum, Mycobacterium tusciae,
Mycobacterium brumae, Mycobacterium duvalii, M. Szulgai, and Mycobacterium
gadium) did not exist, just as they did not exist in Nocardia. Besides, revealing that
Nocardia ignorata and Nocardia cerradoensis have BstE II cutting patterns makes
one think that the estimated deﬁnition can be inconvenient. In addition, the fact that
Hae III patterns are different than the algorithm deﬁned by Chimara et al. [12]
explains why Nocardias are not deﬁned due to the enzymes used in the PRA
method. At 235-120-100 bp, cutting patterns were observed in the other isolate
undeﬁned by the PRA method, the BstE II enzyme, but could not be deﬁned
because the Hae III and band patterns were not observed. The sequence analysis
deﬁned it as M. intracellulare. Sequence analysis is superior to the PRA in its
ability to deﬁne these types.
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The isolate deﬁned asM. gordonae type 6 by the PRA method was deﬁned
as M. senegalense (99% compatible with the reference sequence) by sequence
analysis. The internet site prasite deﬁnes four types of M. senegalense. While
BstE II cutting patterns of M. senegalense type 2 and M. senegalense type 6 are
the same (235/130/85 bp), their Hae III cutting patterns are different (140/125/
60/50 bp and 140/120/95 bp, respectively). M. gordonae can easily be obtained
from fresh water, water installations, and laboratory taps. A slow-growing
mycobacteria is generally considered a contaminant [5]. M. senegalense, how-
ever, is a fast-growing mycobacteria and generally leads to infections affecting
cattle in East Africa. It is reported to have caused catheter-related bacteremia for
a patient with immune deﬁciency and soft tissue infection related to an aquarium
glass cut in a normal healthy child [24, 25]. Although we do not have the
patient’s clinical data, deﬁning it as M. senegalense or wrongly as M. gordonae
type 6 would not create a problem for the patient as these do not cause any
infection in the respiratory tract.
It is important to know the culture positivity ratios in mycobacteriology
laboratories. If the ratios are higher than expected, the laboratory supervisor
should take note. Successive positivity in the samples coming from the bron-
choscopy unit, with the same factor isolated, could signal a problem in the
sterilization of endoscopic material [26]. In addition, the NTMs may lead to
pseudo-positivity in the cultures by contamination of the tampons and water used
in laboratories. If these pseudo-infections can be detected, people can be
prevented from unnecessary treatments.
The lack of evidence related to person-to-person infection and the fact that
people generally get infected by NTMs from the environment presents an
important problem concerning the studies about the epidemiology of NTMs.
People become exposed to NTMs by drinking tap water, swimming, or inhaling
aerosols while taking a shower. To understand whether the NTMs detected in this
study are causative agents or contaminants, and their epidemiological meanings,
more comprehensive clinical work is needed.
In summary, the PRA method is an easily applicable method that gives
results quickly. Compared with DNA sequence analysis, it gives over 90%
compatible and reliable results. For NTM-suspected samples undeﬁned by the
PRA, other microorganisms should be considered. DNA sequence analysis is the
gold standard method and has deﬁned all our strains. However, as it is not a
method we apply directly in our laboratory, a disadvantage is that it takes longer to
reach a diagnosis than through the PRA method. For patient management and
follow-up treatment, the NTM results should be considered with the clinical
ﬁndings.
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